CRCharmaine D. M. Royal

Charmaine D. M. Royal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Charmaine D. M. Royal has a total of 120 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • “What does racial equity mean to you?” ¾ Using photovoice to explore college students’ viewpoints

    by Xifan Yang, Morgan Payne, Yingwei Yang, Charmaine Dm Royal

    Racial disparities often lead to health disparities among racial and ethnic minorities, affecting overall health and quality of life. Additionally, racial and ethnic minorities report more perceived racism and discrimination, which is also significantly associated with negative health outcomes. The purpose of this study was to explore how college students understand and define racial equity using photovoice. This study engaged 11 college students in North Carolina through photovoice, a qualitative research method, which utilized photo-taking and discussions to explore U.S. college students’ perspectives on racial equity. Participants took 10-15 photos that represented their perspectives on racial equity. Following submission of the photos, a follow-up interview was conducted for participants to discuss the images, explain opinions on racial disparities, and provide recommendations for improving racial equity. Photos and photo discussions were transcribed, coded, and analyzed by the research team. This study identified five emerging themes, including 1) equal opportunities (e.g., high-quality educational opportunities, job opportunities, opportunity for success), 2) tangible support (e.g., large company support, community support), 3) social connectedness (e.g., working together, sharing and enjoying other cultures), 4) safe and inclusive environments (e.g., personal and environmental safety, inclusive environments), and 5) health justice (e.g., accessible health care, food security). The emerging themes identified in this study provide insights into how college students understand racial equity and might inform efforts to promote equity in college and community settings. Future research should continue exploring this topic and addressing racial equity concerns.

  • Open Access

    Implementation of the National Collegiate Athletic Association (NCAA) Sickle Cell Trait Screening Policy: Methods and Staff and Athlete Perspectives

    by Kristen L. Kucera, Robert P. Agans, Paul A. Robbins, Yingwei Yang, Lorrie Schmid, Mary Anne McDonald, Paul H. Haagen, Mina Silberberg, Deborah L. Marean, Charmaine D.M. Royal

    Introduction: This paper describes methods for a national study evaluating the implementation of the National Collegiate Athletic Association’s (NCAA) policy on sickle cell trait (SCT) screening of athletes and describes attitudes toward the screening. Methods: In Fall 2020, 343 Division I schools, 302 Division II schools, and 426 Division III schools were invited to participate in this national survey. Results: Across 123 participating schools, a total of 168 sport medicine administrators (121 head athletic trainers and 47 team physicians), 268 athletic staff (128 staff athletic trainers and 140 coaches), and 1424 athletes from basketball, football, soccer, lacrosse, track and field completed the survey. While the vast majority of respondents agreed/strongly agreed with the screening policy, there was varying support for how the policy was implemented including: prioritizing SCT screening versus screening for other conditions (40-50% agreed/strongly agreed), focusing on sports with higher risk of overexertion versus universal screening (50-75% agreed/strongly agreed), and focusing on racial and ethnic groups where SCT is more prevalent (25-40% agreed/strongly agreed). Perspectives varied by NCAA division and race. Higher SCT knowledge scores were associated with believing that screening all athletes for SCT is important. Conclusions: Discussion of these findings provides important context for assessing how genetic screening requirements are implemented within collegiate athletics and more broadly.

  • Open Access

    Facilitators and Barriers to Newborn Sickle Cell Screening in Kalangala, Uganda

    by Madison K. Kitts, Joan Namata Perroni, Carol Nambwere, Julius Watema, Brian Herbert Ssemanda, Charmaine D.M. Royal, Stephanie O. Ibemere, Deogratias Munube, Joel Kibonwabake, Kearsley A. Stewart

    Background: Sickle cell disease (SCD) is the most common inherited blood disorder worldwide. In Uganda, fifth in global prevalence, about 40,000 children are born with SCD annually. Newborn screening (NBS) enables early diagnosis and reduces mortality. Despite Uganda adopting universal NBS policies, little is known about factors affecting implementation in isolated areas. This study examined barriers and facilitators to NBS for SCD in Kalangala District, an island district in Lake Victoria, Uganda. Objectives: This study investigates challenges and facilitators to Uganda Ministry of Health’s (MoH’s) call for universal NBS in a low‑resource area and describes parent perspectives of NBS. Methods: We conducted a mixed‑methods study with surveys (N = 271) and in‑depth interviews (N = 32) with parents of children under two years old about Kalanglala Health Center IV’s NBS program and their attitudes toward it. Data from surveys, in‑depth interviews, and KHCIV’s annual NBS data assessed NBS capacity. Statistical analysis was conducted in RStudio and Excel; qualitative analysis was conducted in NVivo. Findings: Among 271 participants, 83.8% had heard of SCD, but only 51.5% knew it is an inherited blood disorder. Most (61.6%) were unaware of the NBS at Kalangala Health Center IV, yet 81.5% would recommend screening. Most (51.3%) saw the first two days after birth as the best screening time. Of 455 records, SCD prevalence was 2.4%, higher than the national 0.7%. Qualitative findings highlighted limited knowledge, stigma, transportation, cost, and mistrust as barriers, while facilitators included trust in healthcare workers, positive screening experiences, and integration into community outreach. Conclusions: Universal NBS for SCD is feasible in remote areas like Kalangala District, but barriers such as educational, geographic, financial, and health system issues threaten sustainability. Integrating SCD education into antenatal and immunization services, initiating community outreaches, and improving access to specialized care are key to nationwide scale‑up.

  • A Campus Narrative of a Research-Informed Visioning Process

    by Patricia Garrett-Peters, Jayne Ifekwunigwe, Lorrie Schmid, Charmaine Royal

    The vision, mission, and goals of the Duke Center for Truth, Racial Healing & Transformation (Duke TRHT Center) align with those of Duke University and are guided by the framework and principles of the national TRHT Movement. As an institution, Duke continues to reckon with its historical and current narratives and create new ones, to promote and practice its five core values, and to remake institutional policies. The Duke TRHT Center is a campus-wide entity that strives to address both the roots and consequences of racism by helping to alter beliefs, attitudes, and actions. Research, education, and engagement are three key strategies that the center uses to accomplish its goals. This essay presents the center’s research, which aims to provide an accurate recounting of local and national histories of and perspectives on race and racism. The center is utilizing archival research and longitudinal qualitative and quantitative research methods to uncover and understand patterns and mechanisms and to translate its findings into models that demonstrate or cultivate individual, interpersonal, and institutional transformation. This campus essay illustrates how research can inform TRHT visioning work.

  • Open Access

    Guidelines for genetic ancestry inference created through roundtable discussions

    by Jennifer K. Wagner, Joon-Ho Yu, Duana Fullwiley, CeCe Moore, James F. Wilson, Michael J. Bamshad, Charmaine D. Royal


  • Open Access

    Science, Society, and Dismantling Racism

    by Charmaine D.M. Royal

    As a foundational pillar of the Truth, Racial Healing & Transformation framework, Narrative Change involves reckoning with our historical and current realities regarding “race” and racism, uprooting dominant narratives that normalize injustice and sustain oppression, and advancing narratives that promote equity and collective liberation. Narrative Change is vital to creating communal recognition and appreciation of the interconnectedness and equality of all humans and dismantling the ideology and structures of racial hierarchy. Telling new or more truthful and complete stories must include improving our understanding and messaging about what race is and what it is not as well as the relationship between race and racism. Ideas about the existence of biological human races have long been discredited by scientists and scholars in various fields. Yet, false beliefs about natural and fixed biological differences within the human species persist in some scientific studies, in aspects of health care, and in the political and legal architectures of the United States and other countries, thereby reproducing and maintaining social hierarchies. Efforts to eradicate racism and its pernicious effects are limited in their potential for sustained positive transformation unless simultaneous endeavors are undertaken to reframe people's thinking about the very concept of race. This brief provides an overview of the origins of racial hierarchy, distinguishes between biological concepts of race and socially defined race, reviews perspectives on the meanings and uses of race, and describes ongoing and potential efforts to address prevailing misunderstandings about race and racism.


  • Cardiologists’ Perspectives on BiDil and the Use of Race in Drug Prescribing

    by Shawneequa L. Callier, Perry W. Payne, Deborah Akinniyi, Kaitlyn McPartland, Terry L. Richardson, Mark A. Rothstein, Charmaine D. M. Royal

    Objectives We explored cardiologists’ attitudes and prescribing patterns specific to the use of generic isosorbide dinitrate and hydralazine hydrochloride, and the fixed-dose patented drug, BiDil. Background Since the Food and Drug Administration approved BiDil in 2005 with an indication for self-identified black patients, disagreement about the appropriateness of race-based drugs has intensified and led to calls for providers and researchers to abandon race-based delimitations. This paper reports empirical evidence of cardiologists’ views on BiDil’s race-based indication and their ongoing inertia with respect to the debate about BiDil. Methods We conducted a 2010 cross-sectional online survey of members of the Association of Black Cardiologists. Results Fifty-nine cardiologists responded to the survey. Most participants (62.7%) prescribed BiDil to their patients. More than 40% of respondents did not prescribe BiDil to any non-African Americans. When considering whether to prescribe BiDil, a patient’s race determined by physician assessment was the third most important factor considered by participants. The majority of participants (72.7%) selected symptoms as the most important factor. Most participants (59.2%) perceived race as defining biologically distinct individuals. Respondents prescribed BiDil more often to African American patients than non-African American patients. However, they prescribed the generic components that makeup BiDil to African Americans and non-African American patients similarly. Conclusions The survey provides useful findings that, when viewed within the context of ongoing debates about race-based medicine, show little progress toward appropriately utilizing BiDil to maximize health outcomes, yet, might inform the development of practical and effective guidelines concerning the use of race in medicine.


  • Open Access

    Translational Science, DNA Commercialization, and Informed Consent: The Need for Specific Terminology, Insights from a Review of H3Africa Projects

    by Patricia Marshall, Charmaine D.M. Royal, Ruth Chadwick

    In the past decade, there has been an acceleration in genomic research, its applications, and its translation into healthcare products and services for the benefit of public health. These advances are critical to realizing the potential of genomic research for facilitating improved health and disease prevention, diagnosis, and treatment. Despite its tremendous opportunities, the dynamic and increasingly global landscape of genomic research commercialization has been accompanied by a variety of ethical challenges and concerns. The potential for unauthorized use of DNA samples from African people to develop a DNA chip amplifies discussion on the meanings, implications, and impacts of commercialization, benefit sharing, and appropriate consent in genomic research. Leadership of the Human Heredity and Health in Africa (H3Africa) Consortium convened a panel of experts to review research ethics practices employed in H3Africa Consortium projects and make recommendations regarding commercialization. Eighteen investigators submitted documents for projects involving data sharing and use of genetic information. A total of 39 informed consent documents associated with the 18 projects were reviewed. All 18 projects specified that samples would be used in future research. Less than half of the projects included language noting that samples could be used in drug or product development, that DNA samples would not be sold, and that profits would not be shared with participants. Four projects referred to commercialization. Analysis of information included in consent documents contributed to the development of a Commercialization Typology. The Typology identifies factors to consider regarding acceptability of particular instances of commercialization. DNA samples for translational research in product development require a transparent commercialization framework to inform the consent process.


  • Open Access

    “Pain is Subjective”: A Mixed-Methods Study of Provider Attitudes and Practices Regarding Pain Management in Sickle Cell Disease Across Three Countries

    by Kearsley A. Stewart, Monika Parshad-Asnani, Ambroise Wonkam, John Bollinger, Valentina Ngo Bitoungui, Edmond Wonkam-Tingang, Jill Powell, Kathia Desronvil, Kathryn R.K. Benson, Abby Clark, et al.


  • Open Access

    Sickle cell disease is a global prototype for integrative research and healthcare

    by Charmaine D. M. Royal, Michael Babyak, Nirmish Shah, Shantanu Srivatsa, Kearsley A. Stewart, Paula Tanabe, Ambroise Wonkam, Monika Asnani

    Differences in health outcomes and treatment responses within and between global populations have been well documented. There is growing recognition of the need to move beyond simple inventories and descriptions of these differences and our linear explanations for them, and gain a better understanding of the multifaceted systems and networks underlying them in order to develop more precise and effective remedies. Typical targets for such integrative research have been common multifactorial diseases. We propose sickle cell disease, one of the most common monogenic diseases, as an ideal candidate for elucidating the complexity of the influences of endogenous and exogenous factors on disease pathophysiology, phenotypic diversity, and variations in responses to treatments at both the individual and population levels. We provide data‐informed representations of diverse contributors to sickle cell disease complications that could guide innovative efforts to advance scientific knowledge, clinical practice, and policy formulation related to the disease; help improve outcomes for people worldwide with sickle cell disease; and inform approaches to studying and addressing other diseases.